HIV/AIDS患者心血管疾病流行情况及风险预测模型应用评价  

Evaluation on cardiovascular disease prevalence in HIV/AIDS patients and risk prediction models application

作　　者：刘怡涵(综述) 刘俊 金永梅 曹颖婷 白劲松(审校) LIU Yihan;LIU Jun;JIN Yongmei;CAO Yingting;BAI Jinsong(School of Public Health,Dali University,Dali Yunnan 671000,China;First Department of Infection Disease,Third People's Hospital of Kunming/Yunnan Provincial Clinical Medical Center for Infectious Diseases,Kunming Yunnan 650041,China)

机构地区：[1]大理大学公共卫生学院,云南大理671000 [2]昆明市第三人民医院/云南省传染性疾病临床医学中心感染一科,云南昆明650041

出　　处：《云南医药》2024年第6期70-74,共5页Medicine and Pharmacy of Yunnan

基　　金：昆明市卫生科技项目(2023-03-08-019)。

摘　　要：HIV感染者合并CVD已经成为全球性公共卫生问题。许多CVD预测模型在国内外研究中用于评估患者的发病风险,但在女性群体、HIV感染者以及其他疾病中的适用性有限,需要考虑加入特异性危险因素。目前国内HIV感染者CVD预测研究主要为横断面设计,样本量小且研究数量不足,难以准确评估风险与模型之间的关系。故本文拟简要综述HIV合并CVD流行病学情况及国内外风险模型的应用评价,以期为临床工作者正确选择风险预测模型,并开发适用于本国HIV感染者的特异性CVD风险预测模型提供理论依据。The coexistence of cardiovascular disease(CVD)in human immunodeficiency virus(HIV)infection people has become a global public health problem.A number of CVD prediction models have been used in domestic and foreign studies to evaluate the morbidity risk in patients.However,their applicability is limited in female populations,HIV-infected patients,and other diseases.The incorporation of specific risk factors is a necessary consideration in this regard.At present,domestic studies on CVD prediction of HIV-infected patients are predominantly cross-sectional design,with relatively small sample sizes and insufficient number of studies,making it difficult to accurately assess the relationship between risk and the model.Therefore,this paper aims to briefly reviews the epidemiological characteristics of HIV-associated CVD and the application evaluation of risk models at home and abroad,in order to provide theoretical basis for clinicians to correctly select risk prediction models and develop specific CVD risk prediction models suitable for HIV-infected patients in their own country.

关 键 词：艾滋病 人类免疫缺陷病毒感染者 心血管疾病风险 风险预测模型 

分 类 号：R512.91[医药卫生—内科学] R54[医药卫生—临床医学]